Is RDW a clinically relevant prognostic factor for newly diagnosed multiple myeloma? A systematic review and meta-analysis.

Chen, Xiaomin; Liu, Jiayue; Duan, Jialin; Xiong, Hao; Liu, Yang; Zhang, Xinwen; Huang, Chunlan

Chen, Xiaomin; Liu, Jiayue; Duan, Jialin; Xiong, Hao; Liu, Yang; Zhang, Xinwen; Huang, Chunlan.

Afiliação

Chen X; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
Liu J; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
Duan J; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
Xiong H; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
Liu Y; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
Zhang X; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China.
Huang C; Stem Cell Laboratory, Affiliated Hospital of Southwest Medical University, Luzhou City, Sichuan Province, China. huangchunlan@swmu.edu.cn.

BMC Cancer ; 22(1): 796, 2022 Jul 19.

Article em En | MEDLINE | ID: mdl-35854269

Assuntos

Índices de Eritrócitos; Mieloma Múltiplo; Humanos; Mieloma Múltiplo/diagnóstico; Prognóstico; Modelos de Riscos Proporcionais

Palavras-chave

Meta-analysis; Multiple myeloma (MM); Prognosis; Red cell distribution width (RDW)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índices de Eritrócitos / Mieloma Múltiplo Tipo de estudo: Diagnostic_studies / Guideline / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google